Orion
Phase 2Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients.
Founded
1990
Focus
DiagnosticsSmall Molecules
About
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients.
Funding History
2Total raised: $65M
Series A$55MF-Prime CapitalOct 15, 2021
Seed$10MUndisclosedMar 15, 2020
Company Info
TypePrivate
Founded1990
LocationLondon, United Kingdom
StagePhase 2
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile